Recent Updates
Recently added Catalysts
LNTH Neutral Sentiment

Q2 2026 Lantheus Earnings Conference Call

Key Takeaway: Lantheus held its Q2 2026 earnings conference call on August 6, 2026, at 8:00 AM EDT. The call provided insights into the company's financial performance and future outlook. Details regarding earnings and strategic initiatives were discussed during the session.

Market Sentiment Analysis

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+73%
120-day peak, hindsight
Typical move
2.3%
average across 6 past catalysts
Lead asset
Perflutren Lipid microsphere
Phase 2 · Chronic Kidney Diseases

Full Press Release Details

August 6, 2026 8:00 AM EDT : Q2 2026 Lantheus Earnings Conference Call
The post Q2 2026 Lantheus Earnings Conference Call appeared first on Lantheus .
Last updated: Aug 6, 2026